Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-30

Clinical Trial Update: To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated potential drug-drug interactions between the dapivirine vaginal ring (25 mg) and clotrimazole 1% topical cream; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole 1% Cream (clotrimazole)
  • Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV- Prevention | Phase 1 | Status: COMPLETED